Found 4 hits for monomerid = 261487 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Substance-P receptor
(Homo sapiens (Human)) | BDBM261487
(US10011568, Ex. No. 10 | US9708266, 10)Show SMILES CC(C1CCC(CC1)c1cc(c(cn1)N(C)C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)-c1ccc(F)cc1C)C(O)=O |(-8,-6.54,;-8,-5,;-6.67,-4.24,;-6.67,-2.7,;-5.33,-1.93,;-4,-2.7,;-4,-4.24,;-5.33,-5.01,;-2.67,-1.93,;-2.67,-.39,;-1.33,.38,;,-.39,;,-1.93,;-1.33,-2.7,;1.33,.38,;1.33,1.92,;2.67,-.39,;2.67,-1.93,;4,.38,;3.23,1.72,;4.77,1.72,;5.33,-.39,;5.33,-1.93,;6.67,-2.7,;8,-1.93,;8,-.39,;6.67,.38,;9.34,.38,;10.67,-.39,;9.34,1.92,;10.67,1.15,;6.67,-4.24,;8,-5.01,;5.33,-5.01,;6.67,-5.78,;-1.33,1.92,;,2.69,;,4.23,;-1.33,5,;-1.33,6.54,;-2.67,4.23,;-2.67,2.69,;-4,1.92,;-9.34,-4.23,;-10.67,-5,;-9.34,-2.69,)| Show InChI InChI=1S/C34H35F7N2O3/c1-18-12-25(35)10-11-26(18)27-16-28(21-8-6-20(7-9-21)19(2)30(44)45)42-17-29(27)43(5)31(46)32(3,4)22-13-23(33(36,37)38)15-24(14-22)34(39,40)41/h10-17,19-21H,6-9H2,1-5H3,(H,44,45) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.79 | n/a | n/a | n/a | n/a | 7.4 | 25 |
KISSEI PHARMACEUTICAL CO., LTD.
US Patent
| Assay Description The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ... |
US Patent US9708266 (2017)
BindingDB Entry DOI: 10.7270/Q2HM5BGS |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM261487
(US10011568, Ex. No. 10 | US9708266, 10)Show SMILES CC(C1CCC(CC1)c1cc(c(cn1)N(C)C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)-c1ccc(F)cc1C)C(O)=O |(-8,-6.54,;-8,-5,;-6.67,-4.24,;-6.67,-2.7,;-5.33,-1.93,;-4,-2.7,;-4,-4.24,;-5.33,-5.01,;-2.67,-1.93,;-2.67,-.39,;-1.33,.38,;,-.39,;,-1.93,;-1.33,-2.7,;1.33,.38,;1.33,1.92,;2.67,-.39,;2.67,-1.93,;4,.38,;3.23,1.72,;4.77,1.72,;5.33,-.39,;5.33,-1.93,;6.67,-2.7,;8,-1.93,;8,-.39,;6.67,.38,;9.34,.38,;10.67,-.39,;9.34,1.92,;10.67,1.15,;6.67,-4.24,;8,-5.01,;5.33,-5.01,;6.67,-5.78,;-1.33,1.92,;,2.69,;,4.23,;-1.33,5,;-1.33,6.54,;-2.67,4.23,;-2.67,2.69,;-4,1.92,;-9.34,-4.23,;-10.67,-5,;-9.34,-2.69,)| Show InChI InChI=1S/C34H35F7N2O3/c1-18-12-25(35)10-11-26(18)27-16-28(21-8-6-20(7-9-21)19(2)30(44)45)42-17-29(27)43(5)31(46)32(3,4)22-13-23(33(36,37)38)15-24(14-22)34(39,40)41/h10-17,19-21H,6-9H2,1-5H3,(H,44,45) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research
| Assay Description A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ... |
J Med Chem 52: 5013-6 (2009)
BindingDB Entry DOI: 10.7270/Q2HT2RQT |
More data for this Ligand-Target Pair | |
Substance-P receptor
(Homo sapiens (Human)) | BDBM261487
(US10011568, Ex. No. 10 | US9708266, 10)Show SMILES CC(C1CCC(CC1)c1cc(c(cn1)N(C)C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)-c1ccc(F)cc1C)C(O)=O |(-8,-6.54,;-8,-5,;-6.67,-4.24,;-6.67,-2.7,;-5.33,-1.93,;-4,-2.7,;-4,-4.24,;-5.33,-5.01,;-2.67,-1.93,;-2.67,-.39,;-1.33,.38,;,-.39,;,-1.93,;-1.33,-2.7,;1.33,.38,;1.33,1.92,;2.67,-.39,;2.67,-1.93,;4,.38,;3.23,1.72,;4.77,1.72,;5.33,-.39,;5.33,-1.93,;6.67,-2.7,;8,-1.93,;8,-.39,;6.67,.38,;9.34,.38,;10.67,-.39,;9.34,1.92,;10.67,1.15,;6.67,-4.24,;8,-5.01,;5.33,-5.01,;6.67,-5.78,;-1.33,1.92,;,2.69,;,4.23,;-1.33,5,;-1.33,6.54,;-2.67,4.23,;-2.67,2.69,;-4,1.92,;-9.34,-4.23,;-10.67,-5,;-9.34,-2.69,)| Show InChI InChI=1S/C34H35F7N2O3/c1-18-12-25(35)10-11-26(18)27-16-28(21-8-6-20(7-9-21)19(2)30(44)45)42-17-29(27)43(5)31(46)32(3,4)22-13-23(33(36,37)38)15-24(14-22)34(39,40)41/h10-17,19-21H,6-9H2,1-5H3,(H,44,45) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.79 | n/a | n/a | n/a | n/a | n/a | n/a |
Wyeth Research
| Assay Description The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ... |
J Med Chem 52: 5013-6 (2009)
BindingDB Entry DOI: 10.7270/Q2HT2RQT |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM261487
(US10011568, Ex. No. 10 | US9708266, 10)Show SMILES CC(C1CCC(CC1)c1cc(c(cn1)N(C)C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)-c1ccc(F)cc1C)C(O)=O |(-8,-6.54,;-8,-5,;-6.67,-4.24,;-6.67,-2.7,;-5.33,-1.93,;-4,-2.7,;-4,-4.24,;-5.33,-5.01,;-2.67,-1.93,;-2.67,-.39,;-1.33,.38,;,-.39,;,-1.93,;-1.33,-2.7,;1.33,.38,;1.33,1.92,;2.67,-.39,;2.67,-1.93,;4,.38,;3.23,1.72,;4.77,1.72,;5.33,-.39,;5.33,-1.93,;6.67,-2.7,;8,-1.93,;8,-.39,;6.67,.38,;9.34,.38,;10.67,-.39,;9.34,1.92,;10.67,1.15,;6.67,-4.24,;8,-5.01,;5.33,-5.01,;6.67,-5.78,;-1.33,1.92,;,2.69,;,4.23,;-1.33,5,;-1.33,6.54,;-2.67,4.23,;-2.67,2.69,;-4,1.92,;-9.34,-4.23,;-10.67,-5,;-9.34,-2.69,)| Show InChI InChI=1S/C34H35F7N2O3/c1-18-12-25(35)10-11-26(18)27-16-28(21-8-6-20(7-9-21)19(2)30(44)45)42-17-29(27)43(5)31(46)32(3,4)22-13-23(33(36,37)38)15-24(14-22)34(39,40)41/h10-17,19-21H,6-9H2,1-5H3,(H,44,45) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | 7.4 | 25 |
KISSEI PHARMACEUTICAL CO., LTD.
US Patent
| Assay Description A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ... |
US Patent US9708266 (2017)
BindingDB Entry DOI: 10.7270/Q2HM5BGS |
More data for this Ligand-Target Pair | |